Alphatec gains Stout vertebroplasty system
This article was originally published in Clinica
Executive Summary
Spinal surgery specialist Alphatec is to enter the fast-growing vertebroplasty market, having secured exclusive worldwide rights to the V-Stent vertebroplasty system, a product developed by Stout Medical Group. Alphatec will work with Perkasie, Pennsylvania-based Stout in developing the product through its subsidiary Alphatec Spine, headquartered in Carlsbad, California, and will be responsible for commercialising the device.